PCOD (Polycystic Ovarian Disease) and PCOS (Polycystic Ovarian Syndrome) are two closely related conditions that affect the ovaries and hormonal balance in women of reproductive age. They’re often used interchangeably, but they differ in severity, how they affect the body, and how they’re treated. PCOS is the more serious of the two and is recognized as a distinct endocrine disorder, while PCOD is generally a milder condition that often responds well to lifestyle changes alone.
How PCOD and PCOS Differ
In a normal menstrual cycle, the ovaries take turns releasing a mature egg each month. With PCOD, the ovaries release immature or partially mature eggs instead. These undeveloped eggs can turn into small fluid-filled sacs called cysts, leading to swollen ovaries, hormonal imbalances, and irregular periods. PCOD is largely driven by a combination of hormonal imbalance and genetic tendencies.
PCOS is a disorder of the endocrine system, the network of glands that controls hormones throughout your body. Rather than releasing immature eggs, the ovaries in PCOS produce excess androgens (hormones typically associated with male development), which prevent eggs from maturing properly. Those eggs become cysts that stay trapped in the ovaries instead of being released. Because no ovulation occurs, the uterine lining builds up month after month, which raises the risk of endometrial cancer over time.
The key distinction: PCOD is primarily an ovarian problem, while PCOS is a systemic hormonal disorder with effects that reach well beyond the reproductive system.
Prevalence
PCOD is significantly more common. A study conducted in Southern India and Maharashtra found that 22.5% of menstruating women in those regions had PCOD, compared to about 9.13% with PCOS. Globally, the World Health Organization estimates that PCOS affects 10 to 13% of women of reproductive age, though up to 70% of affected women remain undiagnosed.
Symptoms of Both Conditions
PCOD and PCOS share many of the same visible symptoms because both involve excess androgen production. The difference is usually one of degree. Common signs include:
- Irregular or missed periods: cycles that are unpredictable, unusually long, or absent altogether
- Excess hair growth (hirsutism): coarse hair appearing on the face, chest, or back, driven by elevated androgens
- Acne and oily skin: particularly along the jawline, chin, and upper back
- Weight gain: especially around the abdomen, which can be difficult to lose
- Hair thinning: male-pattern hair loss on the scalp
With PCOS specifically, symptoms tend to be more pronounced. You may also experience patches of darkened skin on the neck or underarms, and the metabolic effects (described below) can produce fatigue and mood changes. Clinicians assess excess hair growth using a standardized scoring system, and a score of 8 or higher out of a possible maximum indicates clinical hirsutism. The presence of noticeable hirsutism alone is considered a strong predictor of elevated androgens and possible PCOS.
How PCOS Is Diagnosed
There is no single test for PCOS. Diagnosis follows internationally recognized criteria that require at least two of the following three features: irregular or absent ovulation, signs of excess androgens (either visible symptoms like hirsutism or elevated levels on a blood test), and polycystic-appearing ovaries on an ultrasound.
Blood tests typically measure total and free testosterone levels. If those come back normal but PCOS is still suspected, doctors may check other androgen markers, though these are less specific. Updated 2023 guidelines also allow a blood test measuring anti-Müllerian hormone (AMH) as an alternative to ultrasound in adult women, which simplifies the process for those who may not have easy access to imaging.
PCOD, by contrast, doesn’t have the same formal diagnostic framework. It’s often identified when ultrasound reveals multiple small cysts on the ovaries alongside irregular periods, but without the broader hormonal disruption that defines PCOS.
Long-Term Health Risks of PCOS
This is where PCOS and PCOD diverge most sharply. PCOD, while uncomfortable and sometimes frustrating, rarely leads to serious long-term complications. PCOS carries genuine metabolic risks that accumulate over time.
More than half of women with PCOS develop type 2 diabetes by age 40, according to the CDC. The connection runs through insulin resistance: the body’s cells stop responding normally to insulin, so the pancreas pumps out more and more of it. That excess insulin, in turn, stimulates the ovaries to produce even more androgens, creating a self-reinforcing cycle. Growing evidence over the past two decades points to defects in insulin signaling as a central driver of the syndrome, not just a side effect.
Beyond diabetes, PCOS increases the risk of heart disease (a risk that climbs with age), high blood pressure, and sleep apnea. The buildup of the uterine lining from months without ovulation also raises the chance of endometrial cancer if left unaddressed.
Managing PCOD
PCOD often responds well to lifestyle adjustments without the need for medication. Regular exercise, a balanced diet that limits refined carbohydrates and added sugars, and maintaining a healthy weight can restore more regular cycles and reduce symptoms like acne and excess hair growth. For many women, these changes are enough to keep PCOD from significantly affecting their quality of life or fertility.
Treating PCOS
PCOS almost always requires more structured treatment because of its endocrine nature. The approach depends on what symptoms matter most to you and whether you’re trying to conceive.
Lifestyle changes remain the foundation. Losing just 5% of your body weight can lead to significant improvement in PCOS symptoms, including more regular periods and better insulin sensitivity. For a person weighing 180 pounds, that’s only about 9 pounds. Even modest changes to diet and activity levels can shift hormonal balance enough to make a noticeable difference.
For insulin resistance, medications that improve the body’s response to insulin are the most widely studied option in PCOS and have a reassuring safety profile. These help lower circulating insulin levels, which in turn reduces androgen production and can restore ovulation in some women.
When fertility is the primary concern, ovulation-inducing medications are typically the first pharmacological step. Research shows they’re most effective as a first-line treatment. For women who don’t respond to ovulation induction alone, combining it with an insulin-sensitizing medication improves outcomes, particularly in women with a BMI under 30. The best combination depends on your body weight and how you respond to initial treatment.
Hormonal contraceptives are commonly prescribed for women who aren’t trying to conceive. They regulate the menstrual cycle, reduce androgen levels, and protect against the endometrial buildup that comes with chronic lack of ovulation.
Fertility With PCOD and PCOS
PCOD rarely causes lasting fertility problems. Because the ovaries do still release eggs (even if they’re immature), many women with PCOD conceive naturally with some lifestyle adjustments or minimal medical support.
PCOS presents a bigger challenge because ovulation may not occur at all. It’s one of the leading causes of difficulty conceiving, but it’s also highly treatable. Most women with PCOS who want to become pregnant can do so with the help of ovulation-inducing medication, sometimes combined with insulin-sensitizing treatment. The process may take longer and require more monitoring, but PCOS does not mean infertility.